Proton versus photon radiotherapy for primary hepatocellular carcinoma: a propensity-matched analysis
Abstract Background Proton radiotherapy has a dosimetric advantage over photon radiotherapy. Many retrospective studies have shown promising results with proton radiotherapy in treating hepatocellular carcinoma (HCC). However, clinical evidence demonstrating the benefit of protons over photons is st...
Main Authors: | Jen-Yu Cheng, Chieh-Min Liu, Yu-Ming Wang, Hsuan-Chih Hsu, Eng-Yen Huang, Tzu-Ting Huang, Ching-Hsin Lee, Sheng-Ping Hung, Bing-Shen Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | Radiation Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13014-020-01605-4 |
Similar Items
-
Assessment of dose perturbations for metal stent in photon and proton radiotherapy plans for hepatocellular carcinoma
by: Boram Lee, et al.
Published: (2022-07-01) -
Dosimetric Comparing between Protons Beam and Photons Beam
for Lung Cancer Radiotherapy: A Meta-analysis
by: Guangwei TIAN, et al.
Published: (2013-05-01) -
Current evidence and the potential role of proton beam therapy for hepatocellular carcinoma
by: Sung Uk Lee, et al.
Published: (2023-10-01) -
CD9- and CD81-positive extracellular vesicles provide a marker to monitor glioblastoma cell response to photon-based and proton-based radiotherapy
by: Sara Jennrich, et al.
Published: (2022-09-01) -
Dosimetric analysis and biological evaluation between proton radiotherapy and photon radiotherapy for the long target of total esophageal squamous cell carcinoma
by: Yongbin Cui, et al.
Published: (2022-10-01)